Influence of sedation on morbidity and mortality in the intensive care unit
Keywords:
Intensive care unit, Complications, APACHE, MortalityAbstract
CONTEXT: Although 30 to 50% of hospitalized patients in a critical care unit are under sedation, there is sparse data on the impact of sedation on morbidity and case-fatality rates in Brazil. Sedation is associated with higher risks of infection and death rate among patients. However, it is difficult to assess the clinical impact of sedation. OBJECTIVE: To evaluate the impact of sedation on the incidence of nosocomial infection and all cause deaths at a critical care unit. TYPE OF STUDY: Prospective study. SETTING: Tertiary-care teaching hospital. PARTICIPANTS: After the exclusion of patients hospitalized for less than 24 hours, 307 patients were assigned to two groups, considering their states of sedation. After confirmation of heterogeneity in relation to the Acute Physiology and Chronic Health Evaluation (APACHE II) prognostic system, 97 sedated and 97 non-sedated patients were matched in relation to this severity index. MAIN MEASUREMENTS: Impact of sedation on deep venous thrombosis, incidence of decubital eschars, presence of infection, mortality and length of hospital stay. RESULTS: There was no difference in the incidence of deep venous thrombosis between the sedated and non-sedated groups, while the frequency of decubital eschars was significantly higher among sedated patients (p = 0.03). Infection was detected in 45.4% of patients under sedation and 21.6% of patients not under sedation (p = 0.006). Mortality for patients that did not receive any kind of sedative was 20.6% and, for those that were sedated during hospitalization, the rate was 52.6% (p < 0.0001). The sedated patients had longer hospitalization (11 vs. 4 days) (p < 0.0001). CONCLUSION: We concluded that sedation is associated with higher infection risk and case-fatality rate, and longer hospital stay.
Downloads
References
Amaral JLG, Rodrigues Jr GR, Rocha, RGA, et al. Sedação. In: Amaral JLG, editor. Clínicas Brasileiras de Medicina Intensiva: Sedação, Analgesia e Bloqueio Neuromuscular em UTI. São Paulo: Editora Atheneu; 1997.p.75-94.
Dobb GJ, Murphy DF. Sedation and Analgesia during Inten- sive Care. Clin Anaesth 1985;3(4):1055-83.
Bion JF, Ledingham IM. Sedation in intensive care - a postal survey. Intensive Care Med 1987;13(3):215-6.
Siegel S. Estatística no Parametrica. Ciudad de Mexico: Ed. Trillas Mexico; 1975.p.346.
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Control- led sedation with alphaxalone-alphadolone. Br Med J 1974; 2(920):656-9.
Aitkenhead AR. Analgesia and sedation in intensive care. Br J Anaesth 1989;63(2):196-206.
Buchanan N, Cane RD. Drug utilization in a general intensive care unit. Intensive Care Med 1978;4(2):75-7.
Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983; 1(8336):1270.
Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984;39(10):973-81.
Ledingham IM, Bion JF, Newman LH, McDonald JC, Wallace PG. Mortality and morbidity amongst sedated intensive care patients. Resuscitation 1988;16(Suppl):S69-77.
Etomidate. Lancet 1983;2(8342):168-9.
Tubaro E, Borelli, G, Croce C, Cavallo G, Santiangeli C. Effect of morphine on resistance to infection. J Infect Dis 1983;148(4):656-66.
Moudgil GC. Effect or premedicants, intravenous anaesthetic agents an local anaesthetics on phagocytosis in vitro. Can Anaesth Soc J 1981;28(6):597-602.
Hole A. Depression of monocytes and lymphocytes by stress- related humoral factors and anaesthetic-related drugs. Acta Anaesthesiol Scand 1984;28(3):280-6.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985;13(10):818-29.
Bion JF, Logan BK, Newman PM, Brodie MJ, Oliver JS, Aitchison TC, Ledingham IM. Sedation in intensive care: morphine and renal function. Intensive Care Med 1986;12(5)359-65.
Wallace PGM, Bion JF, Ledingham IM. The changing face of sedative practice. In: Ledingham IM, editor. Recent Advances in Critical Care Medicine. Edinburgh: Churchill-Livingstone; 1988. p.70-93.
Moritz RD, Goldwasser RS. O uso de analgésicos, sedativos e bloqueadores neuromuscular nas UTIs brasileiras. [Use of seda- tives, analgesics and neuromuscular blocking agents in Brasil ICUs]. Rev Bras Ter Intensiva 1999;11(4):139-45.
Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the in- tensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 1995;23(9):1596-600.
Nasraway Jr SA. Use of Sedative Medications in the Intensive Care Unit. Sem Resp Crit Care Med 2001;22(2):165-74.
Amaral JLG, Réa Neto A, Conceição NA, et al. I Consenso Brasileiro sobre Sedação, analgesia e bloqueio neuromuscular em Terapia Intensiva. In: Amaral JLG, editor. Clínicas Brasileiras de Medicina Intensiva. Sedação, Analgesia e Bloqueio Neuromuscular em UTI. São Paulo: Editora Atheneu; 1997.p.241-55.
Amaral JLG, Issy, AM, Conceição NA, et al. Recomendações da Associação Brasileira de Medicina Intensiva Brasileira sobre analgesia, sedação e bloqueio neuromuscular em Terapia Intensiva. São Paulo: AMIB; 1999.
